1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Dermatophytosis Therapeutics Industry 1.7 COVID-19 Impact: Dermatophytosis Therapeutics Market Trends 2 Global Dermatophytosis Therapeutics Quarterly Market Size Analysis 2.1 Dermatophytosis Therapeutics Business Impact Assessment - COVID-19 2.1.1 Global Dermatophytosis Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Dermatophytosis Therapeutics Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 By Players, Global Dermatophytosis Therapeutics Quarterly Market Size, 2019 VS 2020 3.2 By Players, Dermatophytosis Therapeutics Headquarters and Area Served 3.3 Date of Key Players Enter into Dermatophytosis Therapeutics Market 3.4 Key Players Dermatophytosis Therapeutics Product Offered 3.5 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Dermatophytosis Therapeutics Segments, By Type 4.1 Introduction 1.4.1 Rx 1.4.2 OTC 4.2 By Type, Global Dermatophytosis Therapeutics Market Size, 2019-2021 5 Impact of Covid-19 on Dermatophytosis Therapeutics Segments, By Application 5.1 Overview 5.5.1 Hospital 5.5.2 Clinic 5.5.3 Other 5.2 By Application, Global Dermatophytosis Therapeutics Market Size, 2019-2021 5.2.1 By Application, Global Dermatophytosis Therapeutics Market Size by Application, 2019-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Novartis 7.1.1 Novartis Business Overview 7.1.2 Novartis Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.1.3 Novartis Dermatophytosis Therapeutics Product Introduction 7.1.4 Novartis Response to COVID-19 and Related Developments 7.2 Pfizer 7.2.1 Pfizer Business Overview 7.2.2 Pfizer Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.2.3 Pfizer Dermatophytosis Therapeutics Product Introduction 7.2.4 Pfizer Response to COVID-19 and Related Developments 7.3 Sanofi-Aventis 7.3.1 Sanofi-Aventis Business Overview 7.3.2 Sanofi-Aventis Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.3.3 Sanofi-Aventis Dermatophytosis Therapeutics Product Introduction 7.3.4 Sanofi-Aventis Response to COVID-19 and Related Developments 7.4 Merck 7.4.1 Merck Business Overview 7.4.2 Merck Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.4.3 Merck Dermatophytosis Therapeutics Product Introduction 7.4.4 Merck Response to COVID-19 and Related Developments 7.5 Enzon Pharmaceuticals 7.5.1 Enzon Pharmaceuticals Business Overview 7.5.2 Enzon Pharmaceuticals Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.5.3 Enzon Pharmaceuticals Dermatophytosis Therapeutics Product Introduction 7.5.4 Enzon Pharmaceuticals Response to COVID-19 and Related Developments 7.6 Bayer 7.6.1 Bayer Business Overview 7.6.2 Bayer Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.6.3 Bayer Dermatophytosis Therapeutics Product Introduction 7.6.4 Bayer Response to COVID-19 and Related Developments 7.7 Astellas Pharma 7.7.1 Astellas Pharma Business Overview 7.7.2 Astellas Pharma Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.7.3 Astellas Pharma Dermatophytosis Therapeutics Product Introduction 7.7.4 Astellas Pharma Response to COVID-19 and Related Developments 7.8 GSK 7.8.1 GSK Business Overview 7.8.2 GSK Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.8.3 GSK Dermatophytosis Therapeutics Product Introduction 7.8.4 GSK Response to COVID-19 and Related Developments 7.9 Abbott 7.9.1 Abbott Business Overview 7.9.2 Abbott Dermatophytosis Therapeutics Quarterly Revenue, 2020 7.9.3 Abbott Dermatophytosis Therapeutics Product Introduction 7.9.4 Abbott Response to COVID-19 and Related Developments 8 Key Findings 9 Appendix 9.1 About US 9.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Dermatophytosis Therapeutics Assessment Table 9. COVID-19 Impact: Dermatophytosis Therapeutics Market Trends Table 10. COVID-19 Impact Global Dermatophytosis Therapeutics Market Size Table 11. Global Dermatophytosis Therapeutics Quarterly Market Size, 2020 (US$ Million) Table 12. Global Dermatophytosis Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 13. Global Dermatophytosis Therapeutics Market Growth Drivers Table 14. Global Dermatophytosis Therapeutics Market Restraints Table 15. Global Dermatophytosis Therapeutics Market Opportunities Table 16. Global Dermatophytosis Therapeutics Market Challenges Table 17. By Players, Dermatophytosis Therapeutics Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 18. Key Players, Dermatophytosis Therapeutics Revenue Market Share, 2019 VS 2020 (%) Table 19. Key Dermatophytosis Therapeutics Players Headquarters and Area Served Table 20. Date of Key Players Enter into Dermatophytosis Therapeutics Market Table 21. Key Players Dermatophytosis Therapeutics Product Type Table 22. Mergers & Acquisitions, Expansion Plans Table 23. By Players, Global Dermatophytosis Therapeutics Market Size 2019-2021, (US$ Million) Table 24. Global Dermatophytosis Therapeutics Market Size by Application: 2019-2021 (US$ Million) Table 25. Global Dermatophytosis Therapeutics Market Size by Region, 2019-2021 (US$ Million) Table 26. By Country, North America Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 27. By Type, US Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 28. By Application, US Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 29. By Type, Canada Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 30. By Application, Canada Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 32. By Country, Europe Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 33. By Type, Germany Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 34. By Application, Germany Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 35. By Type, France Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 36. By Application, France Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 37. By Type, UK Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 38. By Application, UK Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 39. By Type, Italy Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 40. By Application, Italy Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 42. By Region, Asia-Pacific Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 43. By Type, China Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 44. By Application, China Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 45. By Type, Japan Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 46. By Application, Japan Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 47. By Type, South Korea Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 48. By Application, South Korea Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 49. By Type, India Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 50. By Application, India Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 51. By Type, ASEAN Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 52. By Application, ASEAN Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 53. By Type, Latin America Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 54. By Application, Latin America Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 55. By Type, Middle East and Africa Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 56. By Application, Middle East and Africa Dermatophytosis Therapeutics Market Size, 2019-2021 (US$ Million) Table 57. Novartis Business Overview Table 58. Novartis Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Novartis Dermatophytosis Therapeutics Product Table 60. Novartis Response to COVID-19 and Related Developments Table 61. Pfizer Business Overview Table 62. Pfizer Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Pfizer Dermatophytosis Therapeutics Product Table 64. Pfizer Response to COVID-19 and Related Developments Table 65. Sanofi-Aventis Business Overview Table 66. Sanofi-Aventis Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Sanofi-Aventis Dermatophytosis Therapeutics Product Table 68. Sanofi-Aventis Response to COVID-19 and Related Developments Table 69. Merck Business Overview Table 70. Merck Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Merck Dermatophytosis Therapeutics Product Table 72. Merck Response to COVID-19 and Related Developments Table 73. Enzon Pharmaceuticals Business Overview Table 74. Enzon Pharmaceuticals Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Enzon Pharmaceuticals Dermatophytosis Therapeutics Product Table 76. Enzon Pharmaceuticals Response to COVID-19 and Related Developments Table 77. Bayer Business Overview Table 78. Bayer Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. Bayer Dermatophytosis Therapeutics Product Table 80. Bayer Response to COVID-19 and Related Developments Table 81. Astellas Pharma Business Overview Table 82. Astellas Pharma Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Astellas Pharma Dermatophytosis Therapeutics Product Table 84. Astellas Pharma Response to COVID-19 and Related Developments Table 85. GSK Business Overview Table 86. GSK Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. GSK Dermatophytosis Therapeutics Product Table 88. GSK Response to COVID-19 and Related Developments Table 89. Abbott Business Overview Table 90. Abbott Dermatophytosis Therapeutics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Abbott Dermatophytosis Therapeutics Product Table 92. Abbott Response to COVID-19 and Related Developments List of Figures Figure 1. Dermatophytosis Therapeutics Product Picture Figure 2. Dermatophytosis Therapeutics Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Dermatophytosis Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Dermatophytosis Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Dermatophytosis Therapeutics Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Dermatophytosis Therapeutics Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Dermatophytosis Therapeutics Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Dermatophytosis Therapeutics Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Dermatophytosis Therapeutics Market Size Market Share, 2019-2021

Novartis Pfizer Sanofi-Aventis Merck Enzon Pharmaceuticals Bayer Astellas Pharma GSK Abbott